up home page bottom

French German version Spanish version Italian version

header image

The Healthcare Sales and Marketing of Gardasil

The Healthcare Sales and Marketing Network
February 17, 2010
Investigational Data Also Presented on Efficacy Against HPV 6,11,16 and 18 – Related Persistent Infection, CIN and EGL in Women Aged 24 Through 45 Naïve to the Relevant HPV Type

In this study, 87 percent of the vaccine group and 81 percent of the placebo group reported one or more AEs. These were predominantly injection-site AEs (77 percent of the vaccine group and 64 percent of the placebo group). Serious adverse events were reported rarely and occurred comparably in the vaccine (0.7 percent) and placebo (0.8 percent) groups, and none were deemed to be vaccine-related by the study investigators.

  • Share/Bookmark

Merck: Studies boost Gardasil for new uses

The Miami Herald

National Business
By LINDA A. JOHNSON
AP Business Writer

TRENTON, N.J. — The Gardasil vaccine protected most ( how many is most??) young women from cervical cancer and homosexual men from anal cancer, according to new studies released Wednesday by its maker, Merck & Co. Studies were conducted by Merck.

Comment from Leslie -the vaccine has only been on the market for 3 years so how can Merck say ANYONE has been protected from cervical cancer? NVIC lists 272 cases of abnormal pap tests post vaccination.

  • Share/Bookmark

Merck Receives European Approval for ELONVA® (corifollitropin alfa injection)

PharmaNews.eu
February 15, 2010

Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program. With the EC approval, Merck receives marketing authorization for ELONVA with unified labeling valid in all European Union Member States. Schering-Plough Corp. and Merck & Co., Inc. merged on Nov. 3, 2009.

Comment from Leslie – And now Merck is coming out with an injection to stimulate ovulation? I would never take an injection from Merck or anyone else to stimulate ovulation especially if it was their initial injection (vaccine) that caused it to stop.

  • Share/Bookmark

Vaccine also has ruined my daughter’s life

Star Exponent

Culpeper, VA

Melinda Weninger, Bismarck, N.D.
Published: February 16, 2010
Updated: February 16, 2010

Thank you so much for the story about Gardasil vaccination (“Local couple questions Gardasil’s safety,” Feb. 7). My daughter Jessica had the vaccination shortly after it was introduced in 2006.

She has been sick ever since. That is over three years later, and she is still suffering adverse side effects.

  • Share/Bookmark

Cervical cancer jab teens being ‘bribed’ with vouchers

Birmingham Mail
February 9, 2010

TEENAGE girls in Birmingham are being offered shopping vouchers to have the controversial HPV cervical cancer jab, it can be revealed today.

If they have the jab the teenagers each get £45 worth of Love2Shop store vouchers.

But the vouchers for jabs scheme was branded “bribery” by the mother of one teenage girl, while another described it as “unethical coercion.”

  • Share/Bookmark

CDC.gov Advertises for Gardasil on Its Home Page

Anthrax Blogspot.com

Meryl Nass
Bar Harbor, Maine, United States

Julie Gerberding moved to Merck last month and CDC simultaneously decided to focus on cervical cancer. What a coincidence! The only cancer mentioned on CDC’s home page is cervical cancer, and a chart of cervical cancer incidence by ethnicity is the only statistical information on the home page.

  • Share/Bookmark

Is the Gardasil Vaccine an Experiment on Your Children?

By Mary Tocco

February 13, 2010

NewsWithViews.com

Since the introduction of the Gardasil vaccine, there has been a growing concern about safety and efficacy. As our vaccine producers come up with more vaccines, we must continue to fight this theory as dangerous and unnecessary. What is a theory about the cause of cancer, having never been proven, are the grounds for this vaccine.

  • Share/Bookmark

[DOC] Women’s organisations oppose HPV vaccines ‘against cervical cancer’ [India]

Business and Human Rights Resource Centre

Saheli Women’s Resource Centre & Sama Resource Group for Women & Health [India]
Dated: 28 Dec 2009

In a public meeting…women’s groups Sama Resource Group…and Saheli Women’s Resource Centre, raised serious objections to the trials, study and marketing of HPV (human papillomavirus) vaccines claiming to protect young girls from cervical cancer in India.

  • Share/Bookmark

Sanofi Pasteur, maker of Gardasil, wins contract to supply cervical cancer vaccine in Ireland

Irish Medical Times
Gary Culliton

gary.culliton@imt.ie

The contract to supply a cervical cancer vaccine which has been awarded to Sanofi Pasteur, the Minister for Health, Mary Harney, confirmed at yesterday’s meeting of the Joint Oireachtas Committee on Health.

The vaccine, Gardasil, will be given to first-year students in second-level schools this year.

  • Share/Bookmark

NZ Ministry of Health Ignored The Warnings Of Its Own Director Of Gardasil Clinical Trials

Web of Evidence
February 4, 2010

Julie Smith, researcher and founder of a New Zealand website set up specifically to give information about the HPV vaccine, Gardasil, www.offtheradar.co.nz, says concerned parents have been contacting her wanting to know how they can help to have the vaccine withdrawn from New Zealand.

After last night’s Close Up on TV 1 Ms Smith says “Many more parents are making the connection to their child’s sudden onset of deteriorating health since receiving the Gardasil vaccine.”

“What is now happening to our girls here in New Zealand is replicating what has already happened overseas. It was only a matter of time before girls here were going to die from this vaccine,” said Ms Smith.

  • Share/Bookmark